Shanghai MicuRx Pharmaceutical Co., Ltd. (SHA:688373)
China flag China · Delayed Price · Currency is CNY
6.15
-0.12 (-1.91%)
At close: Mar 19, 2026

SHA:688373 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
141.77130.2790.7848.217.66
Revenue Growth (YoY)
8.83%43.51%88.31%529.33%-
Cost of Revenue
-22.4116.78.820.76
Gross Profit
141.77107.8774.0839.386.9
Selling, General & Admin
-176.79168.57146.18124.38
Research & Development
-368.56344.86150.39151.76
Other Operating Expenses
386.850.410.30.140.03
Operating Expenses
386.85546.53514.06296.9276.2
Operating Income
-245.07-438.66-439.98-257.52-269.3
Interest Expense
--11.15-10.14-8.82-5.23
Interest & Investment Income
-2.372.194.42.39
Currency Exchange Gain (Loss)
--4.520.02-5.59-0.29
Other Non Operating Income (Expenses)
-0.49-1-0.130.34-0.4
EBT Excluding Unusual Items
-245.57-452.96-448.03-267.19-272.82
Gain (Loss) on Sale of Investments
-17.0833.3418.4910.53
Gain (Loss) on Sale of Assets
-0.0300.49-0.02
Other Unusual Items
-1.34-0.4627.9236.08
Pretax Income
-245.57-434.51-415.15-220.29-226.23
Income Tax Expense
-3.956.215.970.010.04
Net Income
-241.61-440.72-421.12-220.3-226.27
Net Income to Common
-241.61-440.72-421.12-220.3-226.27
Shares Outstanding (Basic)
653656656580526
Shares Outstanding (Diluted)
653656656580526
Shares Change (YoY)
-0.40%-13.09%10.17%106.16%
EPS (Basic)
-0.37-0.67-0.64-0.38-0.43
EPS (Diluted)
-0.37-0.67-0.64-0.38-0.43
Free Cash Flow
--448.1-336.74-252.18-203.89
Free Cash Flow Per Share
--0.68-0.51-0.43-0.39
Gross Margin
100.00%82.80%81.61%81.70%90.08%
Operating Margin
-172.86%-336.72%-484.69%-534.19%-3515.62%
Profit Margin
-170.42%-338.31%-463.91%-456.99%-2953.91%
Free Cash Flow Margin
--343.97%-370.96%-523.13%-2661.81%
EBITDA
-242.81-436.4-437.97-256.22-268.75
EBITDA Margin
-171.27%----
D&A For EBITDA
2.262.262.021.290.55
EBIT
-245.07-438.66-439.98-257.52-269.3
EBIT Margin
-172.86%----
Revenue as Reported
-130.2790.7848.217.66
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.